lithium response
Recently Published Documents


TOTAL DOCUMENTS

154
(FIVE YEARS 44)

H-INDEX

28
(FIVE YEARS 5)

2022 ◽  
Author(s):  
Vipavee Niemsiri ◽  
Sarah Brin Rosenthal ◽  
Caroline M. Nievergelt ◽  
Adam X. Maihofer ◽  
Maria C. Marchetto ◽  
...  

Lithium (Li) is one of the most effective drugs for treating bipolar disorder (BD), however, there is presently no way to predict response to guide treatment. The aim of this study is to identify functional genes and pathways that distinguish BD Li responders (LR) from BD Li non-responders (NR). An initial Pharmacogenomics of Bipolar Disorder study (PGBD) GWAS of lithium response did not provide any significant results. As a result, we then employed network-based integrative analysis of transcriptomic and genomic data. In transcriptomic study of iPSC-derived neurons, 41 significantly differentially expressed (DE) genes were identified in LR vs NR regardless of lithium exposure. In the PGBD, post-GWAS gene prioritization using the GWA-boosting (GWAB) approach identified 1119 candidate genes. Following DE-derived network propagation, there was a highly significant overlap of genes between the top 500- and top 2000-proximal gene networks and the GWAB gene list (Phypergeometric=1.28E-09 and 4.10E-18, respectively). Functional enrichment analyses of the top 500 proximal network genes identified focal adhesion and the extracellular matrix (ECM) as the most significant functions. Our findings suggest that the difference between LR and NR was a much greater effect than that of lithium. The direct impact of dysregulation of focal adhesion on axon guidance and neuronal circuits could underpin mechanisms of response to lithium, as well as underlying BD. It also highlights the power of integrative multi-omics analysis of transcriptomic and genomic profiling to gain molecular insights into lithium response in BD.


2021 ◽  
Vol 53 ◽  
pp. S660
Author(s):  
A. Delgado Sequera ◽  
M. Hidalgo-Figueroa ◽  
C. García-Mompó ◽  
J.M. Montesinos ◽  
J.I. Pérez-Revuelta ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Klaus Oliver Schubert ◽  
Anbupalam Thalamuthu ◽  
Azmeraw T. Amare ◽  
Joseph Frank ◽  
Fabian Streit ◽  
...  

AbstractLithium is the gold standard therapy for Bipolar Disorder (BD) but its effectiveness differs widely between individuals. The molecular mechanisms underlying treatment response heterogeneity are not well understood, and personalized treatment in BD remains elusive. Genetic analyses of the lithium treatment response phenotype may generate novel molecular insights into lithium’s therapeutic mechanisms and lead to testable hypotheses to improve BD management and outcomes. We used fixed effect meta-analysis techniques to develop meta-analytic polygenic risk scores (MET-PRS) from combinations of highly correlated psychiatric traits, namely schizophrenia (SCZ), major depression (MD) and bipolar disorder (BD). We compared the effects of cross-disorder MET-PRS and single genetic trait PRS on lithium response. For the PRS analyses, we included clinical data on lithium treatment response and genetic information for n = 2283 BD cases from the International Consortium on Lithium Genetics (ConLi+Gen; www.ConLiGen.org). Higher SCZ and MD PRSs were associated with poorer lithium treatment response whereas BD-PRS had no association with treatment outcome. The combined MET2-PRS comprising of SCZ and MD variants (MET2-PRS) and a model using SCZ and MD-PRS sequentially improved response prediction, compared to single-disorder PRS or to a combined score using all three traits (MET3-PRS). Patients in the highest decile for MET2-PRS loading had 2.5 times higher odds of being classified as poor responders than patients with the lowest decile MET2-PRS scores. An exploratory functional pathway analysis of top MET2-PRS variants was conducted. Findings may inform the development of future testing strategies for personalized lithium prescribing in BD.


2021 ◽  
Author(s):  
Monica Federoff ◽  
Michael J. McCarthy ◽  
Amit Anand ◽  
Wade H. Berrettini ◽  
Holli Bertram ◽  
...  

2021 ◽  
Vol 51 ◽  
pp. e36
Author(s):  
Divya Mehta ◽  
Anita Sathyanarayanan
Keyword(s):  

2021 ◽  
Vol 51 ◽  
pp. e231
Author(s):  
Azmeraw Amare ◽  
Klaus Oliver Schubert ◽  
Anbupalam Thalamuthu ◽  
Scott Clark ◽  
Thomas G. Schulze ◽  
...  

2021 ◽  
Vol 89 (9) ◽  
pp. S13
Author(s):  
Claudia Pisanu ◽  
Donatella Congiu ◽  
Giovanni Severino ◽  
Paola Niola ◽  
Juan Pablo Lopez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document